- Home
- MNTK vs PMI Comparison
MNTK vs PMI Comparison
Compare MNTK & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MNTK | PMI |
|---|---|---|
| Founded | 1980 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.2M | 202.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNTK | PMI |
|---|---|---|
| Price | $1.35 | $1.23 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | 209.6K | ★ 1.7M |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $176,382,000.00 | N/A |
| Revenue This Year | $17.70 | N/A |
| Revenue Next Year | $16.52 | N/A |
| P/E Ratio | $141.00 | ★ N/A |
| Revenue Growth | ★ 0.37 | N/A |
| 52 Week Low | $1.21 | $0.96 |
| 52 Week High | $2.78 | $13.68 |
Technical Indicators
Market Signals| Indicator | MNTK | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 35.19 | 45.35 |
| Support Level | N/A | N/A |
| Resistance Level | $1.79 | $2.52 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 25.96 | 76.92 |
Price Performance
Historical ComparisonAbout MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.